Canopy (TSX:WEED) Stock Is up an Insane 37.2% Already in 2021

Weed stocks are soaring in January 2021, because the chances of marijuana’s federal legalization in the U.S. are high. Canopy Growth stock is building momentum and should be among the attractive investment options in the sector.

| More on:

Industry leader Canopy Growth (TSX:WEED)(NYSE:CGC) squeezed in a 14.7% total return in 2020, despite a rampaging pandemic. Somehow, the weed stock atoned for its 15.9% loss the year before. However, 2021 could be a different story for cannabis producers and the marijuana sector in general.

As of January 22, 2021, WEED trades at $42.97 per share or a year-to-date gain of 37.2%. Pot stocks, including Canopy Growth, are back in the watch lists of investors. The Democrats have gained control of both houses of Congress in the U.S., which brings marijuana closer to federal legalization.

Canadian pot growers are following the developments intently, because it’s all they need to enter the U.S. market. You know that things are looking up, too, with beverage company Constellation Brands sinking in $200 million more, through warrants, in Canopy Growth in 2020.

Improving revenues

For the fiscal year 2020 (year ended March 31, 2020), a 76% increase in net revenue versus the fiscal year 2019. Fast forward to Q2 fiscal 2021 (quarter ended September 30, 2020), and Canopy Growth posted a record quarterly revenue of $135 million. CEO David Klein attributes the impressive results to the renewed strategy of winning consumer mind share, increased agility, and execution.

Klein adds that Canopy Growth is positioned for continued growth, as the company continues to establish a strong leadership position. For the first half of fiscal 2021, the company showcased a vast portfolio of differentiated brands and products. It includes industry-leading cannabis-infused beverages.

Canopy’s CFO Mike Lee highlights the marked improvement in operating expense. The company is also re-directing its marketing and R&D investments to drive sales. Likewise, management’s end-to-end review was able to identify cost-savings opportunities to the tune of 150 to $200 million. The near-term goal is to accelerate the path to profitability, particularly in Canopy’s largest market, which is Canada.

Larger U.S. market

Canadian and American cannabis companies are hopeful that the Democrat-controlled Congress will pass legislation that would legalize cannabis federally in the United States. Klein expects Canopy Growth to enter and operate in the U.S. in about a year. The market across the border is nine times the size of the market in Canada.

He anticipates seeing a combination of SAFE Banking, a revised Cole memorandum, and reclassification by the executive branch in the next six to eight months. Currently, stock exchange operator TMX Group prohibits Canopy Growth and other Canadian producers from doing business in areas where cannabis is federally illegal.

Competitive advantages

Some analysts give Canopy an advantage over its Canadian counterparts. The company holds warrants to acquire multi-state operator Acreage Holdings no later than 60 days after the federal legalization of cannabis. Furthermore, Canopy will have a distribution framework in the U.S. due to its partnership with Constellation Brands.

Meanwhile, more industry players are gearing to operate in the United States. The merger of Aphria and Tilray will see the birth of a cannabis powerhouse in North America. American counterparts will likewise capitalize on the legal changes. Analysts are speculating again that the marijuana industry will triple in five years.

A trendy sector with risks

Don’t invest in marijuana stocks only because the sector is trending. Evaluate the companies first to see the strong points and growth potentials. You don’t want another bust like the 2019 cannabis crash.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Constellation Brands. The Motley Fool recommends TMX GROUP INC. / GROUPE TMX INC.

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Stocks for Beginners

Buy the Dip Before It’s Too Late: This Canadian Stock Won’t Stay Cheap Forever

Investors might think that cannabis stocks are out, but this one could be the top Canadian stock to consider.

Read more »

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »